NEWS

TRAINING PROGRAM ENROLLMENT FOR SEPTEMBER 2021

Braxia Institute Psilocybin-Assisted TherapyTraining Program Request for Applications for Class of 2022     Application Deadline: July 11, 2021Tentative Program Start Date: September 2021 (pandemic permitting) A total of 14 qualified therapists will be...

read more

BRAXIA SCIENTIFIC INTRODUCES THE BRAXIA INSTITUTE

Over 200 physicians and healthcare providers from Canada, U.S., and Asia to attend Braxia’s Symposium on rapid acting anti-depressants (RAAD) which include ketamine, esketamine and psychedelic therapies Braxia Institute aims to turn research into clinical action to...

read more

CHAMPIGNON BRANDS ANNOUNCES REVOCATION OF CEASE TRADE ORDERS

TORONTO, ONTARIO April 22, 2021 – Champignon Brands Inc. (the “Company”), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), is pleased to announce that the British Columbia Securities Commission and Ontario Securities Commission (the “Commissions”) have revoked their cease trade orders against the Company effective April 22, 2021.

read more

CHAMPIGNON BRANDS ANNOUNCES FILING OF LISTING STATEMENT

TORONTO, ONTARIO, March 26, 2021 /CNW Telbec/ – Champignon Brands Inc. (the “Company”), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), announced today that it has filed a new Listing Statement with the Canadian Securities Exchange (“CSE”) which contains disclosure regarding the acquisition of AltMed Capital Corp. (“AltMed”) (the “Transaction”). The Transaction constituted a reverse takeover of Champignon by AltMed.

read more

CHAMPIGNON BRANDS RESTATES FINANCIAL STATEMENTS AND MD&A Listing statement to be filed

VANCOUVER, BRITISH COLUMBIA – March 11, 2021 – Champignon Brands Inc. (the “Company”), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), announced that as a result of a review by the British Columbia Securities Commission (the “Commission”), the Company has refiled its condensed interim consolidated financial statements and management’s discussion & analysis (“MD&A”) for the three and six month periods ended March 31, 2020 (the “Restated Financial Statements and MD&A”).

read more

CHAMPIGNON BRANDS TO RESTATE FINANCIAL STATEMENTS AND MD&A HAS PREPARED CSE LISTING STATEMENT

VANCOUVER, BRITISH COLUMBIA – February 17, 2021 – Champignon Brands Inc. (the “Company”), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), announced that as a result of a review by the British Columbia Securities Commission (the “Commission”), the Company has determined to withdraw and refile its condensed interim consolidated financial statements and management’s discussion & analysis (“MD&A”) for the three and six month periods ended March 31, 2020 (the “Original Financial Statements and MD&A”).

read more

CHAMPIGNON BRANDS ANNOUNCES NEW CFO AND NEW GENERAL COUNSEL

VANCOUVER, BRITISH COLUMBIA – January 11, 2021 – Champignon Brands Inc. (the “Company”), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), Chairman and CEO Roger McIntyre today announced the Company’s appointment of Stephen R. Brooks as its new Chief Financial Officer and Peter Rizakos as the firm’s new General Counsel.

read more

REVIEW OF BIPOLAR DISORDERS CONFIRMS EARLY DIAGNOSIS AND TREATMENT CAN IMPROVE PATIENT QUALITY OF LIFE

VANCOUVER, BRITISH COLUMBIA – January 8, 2021 – Champignon Brands Inc. (the “Company”), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), announces the publication of an article led by Dr. Roger McIntyre, CEO of Champignon Brands Inc. The article – Bipolar Disorders – is published in one of the world’s best-known and most reputable scientific journals in medicine – The Lancet.

read more